Insomnia as an Independent Behavioral Correlate of Estimated Type 2 Diabetes Risk: Evidence from Three Validated Risk Assessment Scales
Rambam Maimonides Medical Journal · 31.07.2026 · 17 (3) · e0019
DOI: 10.5041/rmmj.10579 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rambam Maimonides Medical Journal, online erschienen am 31.07.2026. Verfasst von José Luis Ribes Valles und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Analysis Laboratory, Son Llatzer Hospital, Palma, Spain. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus, Schlaf
Abstract (Originalsprache)
Background
Sleep disturbances, particularly insomnia, are increasingly recognized as behavioral determinants of type 2 diabetes (T2DM). However, their contribution to validated diabetes risk scores beyond traditional sociodemographic and lifestyle factors remains insufficiently explored.
Objective
To examine the association between insomnia severity, sociodemographic variables, lifestyle habits, and estimated T2DM risk using three validated non-invasive risk assessment scales.
Methods
A cross-sectional study was conducted among 84,898 Spanish workers aged 18–69 years undergoing occupational health evaluations (2021–2024). Sociodemographic and behavioral data were collected through standardized questionnaires, including adherence to the Mediterranean diet (MEDAS-14), physical activity (IPAQ-SF), and smoking status. Insomnia was assessed using the Insomnia Severity Index (ISI). Diabetes risk was estimated using three validated non-invasive risk-assessment tools: the Finnish Diabetes Risk Score, the QDScore/QDiabetes, and the Trinidad Risk Assessment Questionnaire for Type 2 Diabetes Mellitus. As these instruments were developed and validated in different populations, comparisons of absolute risk categories across scales should be interpreted with caution. Multivariable logistic regression models adjusted for age, sex, social class, smoking, diet, and physical activity were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs).
Results
Severe insomnia was associated with approximately 2.1–2.6-fold higher odds of high estimated diabetes risk across all three scales in the pooled analyses, with significant trends across categories of insomnia severity (all P for trend
Autor:innen und Institutionen
- Clinical Analysis Laboratory, Son Llatzer Hospital, Palma, Spain.
- Faculty of Medicine, University of Castilla-La Mancha, Albacete, Spain.
- Faculty of Dentistry ADEMA University School, Palma, Spain.
- Primary Care Balearic Islands Health Service, Palma, Spain.
- Faculty of Medicine, University of the Balearic Islands, Palma, Spain.
Zitieren
APA
Valles, J. L. R., López, P. J. T., González, Á. A. L., Campayo, I. C., Busquets-Cortés, C., & Ramírez-Manent, J. I. (2026). Insomnia as an Independent Behavioral Correlate of Estimated Type 2 Diabetes Risk: Evidence from Three Validated Risk Assessment Scales. Rambam Maimonides Medical Journal, 17(3), e0019. https://doi.org/10.5041/rmmj.10579
Vancouver
Valles JLR, López PJT, González ÁAL, Campayo IC, Busquets-Cortés C, Ramírez-Manent JI. Insomnia as an Independent Behavioral Correlate of Estimated Type 2 Diabetes Risk: Evidence from Three Validated Risk Assessment Scales. Rambam Maimonides Medical Journal. 2026;17(3):e0019. doi:10.5041/rmmj.10579
BibTeX
@article{Valles2026,
author = {Valles, José Luis Ribes and López, Pedro Juan Tárraga and González, Ángel Arturo López and Campayo, Irene Coll and Busquets-Cortés, Carla and Ramírez-Manent, José Ignacio},
title = {Insomnia as an Independent Behavioral Correlate of Estimated Type 2 Diabetes Risk: Evidence from Three Validated Risk Assessment Scales},
journal = {Rambam Maimonides Medical Journal},
year = {2026},
volume = {17},
number = {3},
pages = {e0019},
doi = {10.5041/rmmj.10579}
}
EUVIMED